Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

full text is not available in portal

Category:: Magazine publication
Type:: Magazine publication
Published in:: BONE MARROW TRANSPLANTATION no. 46, edition 6, pages 901 - 903,
ISSN: 0268-3369
ISSN:: 0268-3369
Publication year:: 2011
DOI:: Digital Object Identifier (open in new tab) 10.1038/bmt.2010.202
Verified by:: No verification

seen 48 times

Search